Hologic (HOLX) PT Lowered to $75 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
Hologic (HOLX) PT Raised to $88 at Cowen
February 3, 2022 6:23 AM ESTCowen analyst Max Masucci raised the price target on Hologic (NASDAQ: HOLX) to $88.00 (from $83.00) while maintaining an Outperform rating following results.
The analyst commented, "HOLX delivered a strong FQ1 beat and guided both FQ2 and 2022 (revenues & EPS) well above conservative Street expectations.... More
